- Dr. Sid Mujumdar
- Group Head Late Stage Pharmaceutical Development
- Hoffmann-La Roche, Switzerland
Dr Mujumdar is a pharmaceutical scientist with more than 10 years of experience in Drug Product Development across the US and EU. He received his Ph.D. in Biomedical Engineering from the University of Minnesota and has previously worked in drug produce development at Boehringer Ingelheim, US (early and late NCE development) and Novartis Pharma, Basel (Continuous Manufacturing technology development). Currently, he is a Group Head and Project Leader at Hoffmann-La. Roche, Basel in Late Stage Pharmaceutical development, responsible for market formulation development, scale up and transfer of solid and liquid oral NCE formulations, including tech transfers, filing and process validation activities.